XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Notes Receivable From Stockholders
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at beginning of period at Jun. 30, 2019 $ 31 $ 371,099 $ (88) $ (1,459) $ (345,276) $ 24,307
Balance at beginning of period (in shares) at Jun. 30, 2019 30,478          
Interest on stockholder notes     (1)     (1)
Issuance of common stock upon exercise of stock options   334       334
Issuance of common stock upon exercise of stock options (in shares) 142          
Issuance of common stock in connection with employee stock purchase plan   448       448
Issuance of common stock in connection with employee stock purchase plan (in shares) 69          
Issuance of common stock from public offering, net of issuance costs   29       29
Stock-based compensation   1,393       1,393
Foreign currency translation adjustments       (99)   (99)
Net income         5,057 5,057
Balance at end of period at Mar. 31, 2020 $ 31 373,303 (89) (1,558) (340,219) 31,468
Balance at end of period (in shares) at Mar. 31, 2020 30,689          
Balance at beginning of period at Dec. 31, 2019 $ 31 372,676 (89) (1,650) (342,086) 28,882
Balance at beginning of period (in shares) at Dec. 31, 2019 30,637          
Issuance of common stock upon exercise of stock options   167       167
Issuance of common stock upon exercise of stock options (in shares) 52          
Stock-based compensation   460       460
Foreign currency translation adjustments       92   92
Net income         1,867 1,867
Balance at end of period at Mar. 31, 2020 $ 31 373,303 (89) (1,558) (340,219) 31,468
Balance at end of period (in shares) at Mar. 31, 2020 30,689          
Balance at beginning of period at Jun. 30, 2020 $ 31 374,399 (90) (1,631) (338,068) 34,641
Balance at beginning of period (in shares) at Jun. 30, 2020 30,821          
Interest on stockholder notes     (2)     (2)
Issuance of common stock upon exercise of stock options   944       944
Issuance of common stock upon exercise of stock options (in shares) 214          
Issuance of common stock in connection with employee stock purchase plan   508       508
Issuance of common stock in connection with employee stock purchase plan (in shares) 57          
Stock-based compensation   1,264       1,264
Foreign currency translation adjustments       323   323
Net income         4,911 4,911
Balance at end of period at Mar. 31, 2021 $ 31 377,115 (92) (1,308) (333,157) 42,589
Balance at end of period (in shares) at Mar. 31, 2021 31,092          
Balance at beginning of period at Dec. 31, 2020 $ 31 376,546 (91) (1,270) (334,418) 40,798
Balance at beginning of period (in shares) at Dec. 31, 2020 31,048          
Interest on stockholder notes     (1)     (1)
Issuance of common stock upon exercise of stock options   201       201
Issuance of common stock upon exercise of stock options (in shares) 44          
Stock-based compensation   368       368
Foreign currency translation adjustments       (38)   (38)
Net income         1,261 1,261
Balance at end of period at Mar. 31, 2021 $ 31 $ 377,115 $ (92) $ (1,308) $ (333,157) $ 42,589
Balance at end of period (in shares) at Mar. 31, 2021 31,092